Top HeartFlow Alternatives

Established in 2016, Infervision is a leader in the realm of AI-powered medical technology, committed to improving healthcare operations and interdisciplinary services with cutting-edge artificial intelligence innovations. Their sophisticated AI solutions are crafted to support healthcare practitioners in a variety of functions, such as disease detection, diagnosis, intervention, treatment, patient management, and medical research. Notable among their products is InferRead CT Lung, which excels at identifying lung nodules in chest CT scans, while InferRead DR Chest is focused on uncovering chest abnormalities through X-ray imaging. Additionally, InferRead CT Coronary is specifically designed to detect coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is proficient in assessing brain hemorrhages via CT scans. The company also features InferRead CT Bone for identifying chest fractures in CT images, along with InferRead CT Pneumonia for diagnosing and managing pneumonia cases effectively. Their offerings extend further with InferOperate, which aids in 3D reconstruction for surgical procedures involving the thoracic, liver, and urological regions, as well as InferCare, a tool that enhances patient management and image follow-up. Furthermore, InferScholar serves as an AI-enhanced platform for advancing medical research, reinforcing Infervision's dedication to revolutionizing healthcare through its AI technology. This extensive collection of solutions firmly establishes Infervision as a crucial contributor to the advancement of modern medical practices, highlighting its role in shaping the future of healthcare delivery.

Artrya partners with clinics that focus on patients with chest pain to pioneer advanced AI-driven cardiovascular care models. This collaboration facilitates the integration of high-prognostic value plaque characteristics into the evaluation of coronary artery disease. In both emergency and primary care settings, swift assessments of chest pain patients become achievable. We foresee a future where heart attack occurrences within communities are drastically diminished. By leveraging AI insights from coronary computed tomography angiography (CCTA), healthcare providers can quickly categorize chest pain patients within minutes, based on the type and volume of arterial plaque identified. This innovative technology allows for the prompt detection of individuals with minimal or no coronary artery disease, ensuring that no concealed plaque characteristics are overlooked that could potentially lead to severe cardiac incidents in the future. Identifying early signs of a possible heart attack is of utmost importance. Furthermore, this method enables the effective identification of patients at risk who present with acute or atypical chest pain, guaranteeing they receive appropriate further evaluation and treatment. By adopting this proactive approach, not only are patient outcomes improved, but the overall health of the community is also enhanced, fostering a culture of preventive care. The ongoing commitment to integrating cutting-edge technology will continue to transform cardiovascular care for the better.

Medis Suite XA is our all-encompassing solution for X-Ray angiography, leveraging over thirty years of experience in cardiovascular imaging analysis. This extensive package includes a range of modules, such as an intuitive viewer and specialized analyses focused on coronary and vascular evaluations, which facilitate in-depth anatomical assessments of arteries. Additionally, it provides analyses for both left and right ventricles, along with built-in reporting functionalities to streamline the process. The suite offers sophisticated analyses for coronary and peripheral vessels, known as QCA and QVA, as well as left and right ventriculograms, referred to as QLV and QRV. A particularly noteworthy feature is the groundbreaking QFR® analysis, which assesses the functional significance of lesions without the need for adenosine or a pressure wire, enhancing patient comfort. Furthermore, the suite is designed for smooth integration within existing healthcare IT systems, ensuring straightforward connectivity to the DICOM network to optimize workflow efficiency and elevate patient care standards. Overall, Medis Suite XA marks a pivotal development in the realm of cardiovascular imaging technology, setting a new benchmark for diagnostic precision.

Improve patient outcomes by utilizing the sole objective, quantitative arterial analysis software that has been validated through histology and is based on CTA technology. This groundbreaking tool utilizes authentic histological data to identify the root causes of myocardial ischemia, aiding in the evaluation of risks associated with heart attacks and strokes. These serious medical incidents are frequently triggered by unstable, non-obstructive plaques in the arteries, which often go unnoticed and untreated. Conventional non-invasive diagnostic approaches are inadequate, as they fail to access the deeper layers of arterial walls where the early signs of heart disease appear. Elucid is harnessing cutting-edge scientific imaging along with artificial intelligence to provide swift, accurate, and non-invasive assessments, ultimately allowing for personalized treatment plans for cardiovascular issues and enhanced patient care. With this histology-validated software, you are equipped to analyze plaque characteristics and assess the likelihood of heart attacks and strokes with unparalleled accuracy. This thorough and objective assessment of arterial health enables healthcare professionals to develop individualized treatment strategies long before patients require hospitalization, thereby significantly elevating the standard of healthcare services. Furthermore, such proactive measures not only optimize treatment outcomes but also promote a more efficient healthcare system overall.

We are excited to present an all-encompassing remote patient monitoring solution that caters to the needs of every user. Verustat delivers accurate care for your patients while optimizing your team's efficiency and improving your financial outcomes. Our state-of-the-art at-home monitoring system guarantees that your patients receive the same level of attention as if you were overseeing their care personally. With daily assessments carried out by our remote care coordinators, we help ensure patient adherence and support your ability to qualify for reimbursement. Our dedicated team continually observes your patients, and our secure, HIPAA-compliant online portal and app provide effortless access to the latest biometric information. We assist in managing a range of health issues, including hypertension, obesity, stroke, coronary artery disease, COPD, and diabetes, among various others. Additionally, we offer high-quality connected devices, such as blood pressure monitors, glucometers, pulse oximeters, and scales, which are conveniently sent directly to patients’ homes. This method fosters a more proactive and engaged healthcare experience, benefiting both providers and patients significantly, and ultimately leading to better health outcomes for all involved.

Axial3D is dedicated to improving personalized patient care by transforming the healthcare industry with its cutting-edge 3D medical imaging and bespoke solutions crafted for each individual, thus making customized surgical procedures more routine and widely applicable. Our unique, AI-powered cloud platform empowers medical device manufacturers, imaging experts, and healthcare institutions to generate data-rich, accurate 3D models that enhance surgical planning, improve patient outcomes, and optimize operational efficiency. We offer a range of services, including 3D visualization, mesh files, print-ready files, and tangible 3D models, all designed to integrate seamlessly into existing medical workflows. By converting complex DICOM images into clear and actionable 3D representations, we significantly boost the efficiency, speed, and scalability of developing patient-specific devices. Furthermore, our cloud-based solution provides surgeons with a detailed view of a patient's anatomy prior to surgery, which enhances the accuracy and precision of surgical planning beyond traditional 2D imaging methods. This groundbreaking approach not only serves the needs of individual patients but also contributes to the overarching objective of enhancing surgical practices on a larger scale. Ultimately, we are committed to driving innovation in healthcare, ensuring that every patient receives tailored care that meets their unique needs.

Enhance the success of value-based healthcare by utilizing the OMS Trace Analytics® cloud platform, which excels in analyzing and reporting crucial cardiovascular metrics. As the landscape of reimbursement increasingly prioritizes value, it's noteworthy that during the 2018 performance year, 60% of Medicare payments were linked to quality metrics within the Quality Payment Program. This statistic underscores the urgent need for an accurate, data-driven, and evidence-based quality reporting solution designed to assess, target, and advance your quality initiatives effectively. The OMS Trace Analytics® cloud platform is meticulously designed to deliver deep clinical insights into cardiovascular health, with specialized dashboards concentrating on vital cardiovascular conditions such as Hypertension, Dyslipidemia, Atrial Fibrillation, Heart Failure, Coronary Artery Disease, and Peripheral Artery Disease. By harnessing these sophisticated analytics, healthcare providers can adeptly manage the challenges of value-based care while simultaneously enhancing patient outcomes and overall care quality. Ultimately, this innovative approach fosters a more proactive and informed healthcare environment for both providers and patients alike.

Cleerly is an innovative digital health company that is transforming the approach healthcare professionals take in addressing heart disease. Our cutting-edge clinical technologies empower clinicians to identify and accurately define atherosclerosis at its inception, facilitating the creation of personalized and potentially life-saving treatment options for patients throughout their healthcare experience. Instead of depending on indirect signs such as risk factors or symptoms, we prioritize direct measurements of atherosclerosis, which reflects the buildup of plaque in the heart's arteries. By harnessing our AI-powered digital care pathways, we deliver efficient, quick, and precise diagnostics and reporting that meet the needs of all parties involved, resulting in improved clinical outcomes and financial performance. Cleerly allows healthcare practitioners to go beyond traditional evaluations of heart disease by comprehensively analyzing, characterizing, and quantifying different types of plaque. This forward-thinking strategy not only aids clinicians in evaluating a patient's risk of a heart attack but also supports the development of effective treatment plans aimed at enhancing overall heart health. As a result, we contribute to better patient outcomes and elevate the quality of care provided in the healthcare system. By redefining the standards of heart disease management, Cleerly is setting a new benchmark for patient-focused healthcare.

Altris AI represents a groundbreaking clinical decision support system that utilizes artificial intelligence and operates in the cloud to assist eye care experts in interpreting OCT scans and enhancing their clinical decision-making processes. This innovative platform facilitates the swift identification of pathological OCT scans while demonstrating the capability to recognize more than 70 different retinal pathologies and biomarkers, including some that are relatively rare. Key features include assessing the severity of conditions, analyzing retinal layer thickness, segmenting various layers, detecting pathologies, and executing both automatic and manual measurements. Altris AI is designed to work seamlessly with all OCT devices and supports multiple formats like DICOM, JPEG, and PNG. The system has received FDA clearance and CE certification and complies with GDPR and HIPAA regulations, thus ensuring the highest standards of data security and patient confidentiality. By integrating Altris AI into their clinical workflows, eye care professionals can significantly enhance patient triage, boost diagnostic accuracy, and monitor disease progression more effectively, which contributes to improved patient outcomes. Furthermore, this state-of-the-art technology not only empowers eye care providers to make better-informed decisions but also promotes an overall atmosphere of enhanced patient care and innovative treatment approaches. Ultimately, the adoption of Altris AI can transform the landscape of eye care, leading to advancements in both patient management and clinical practices.

Arterys stands out as a pioneering AI platform for medical imaging that expertly integrates sophisticated AI clinical applications into your existing PACS or EHR systems, ultimately enhancing operational efficiency. By concentrating on enriching the physician's experience, elevating diagnostic precision, improving treatment results, and augmenting financial health, we are transforming AI into a practical tool for healthcare workers. The platform is accessible from any certified device via the cloud, ensuring swift performance and straightforward deployment without requiring the exchange of protected health information, all while maintaining robust security measures. Arterys smoothly interfaces with your PACS, RIS, EMR, and dictation systems, making it an indispensable component of your workflow. Its quick setup demands minimal on-site infrastructure and is commercially viable in over 100 countries, which broadens its accessibility. Our advanced elastic cloud GPU architecture significantly boosts task performance, whether it involves rendering 3D images, processing extensive multi-dimensional datasets, or concurrently executing various AI applications in real-time. In addition, features such as pre-fetching and image caching lead to faster loading times and more efficient analyses. By doing so, Arterys not only simplifies operations but also aligns seamlessly with the ever-changing requirements of contemporary healthcare delivery, ensuring that providers can adapt to future challenges in medical technology.

Caas MR 4D Flow is designed to streamline the extraction of essential data from 3D phase-contrast MR images with remarkable efficiency. By leveraging these sophisticated images, it offers two cutting-edge 4D Flow modules that enable thorough flow analysis, which is crucial for evaluating and interpreting cardiovascular MR images, as well as for planning the timing and type of interventions. One module is dedicated to analyzing blood vessels, from major arteries like the aorta to smaller renal vessels, while the other focuses on heart valves and their regurgitation fractions. Key outputs include the visualization of aortic blood flow through streamlines, pathlines, and color-coded vectors; an in-depth mapping of wall shear stress along with localized shear stress values; assessments of pressure differentials across specific segments; and a comprehensive visualization and quantification of regurgitant fractions across all four heart valves, in addition to performing 2D flow phase-contrast analyses. This multifaceted approach not only deepens the understanding of cardiovascular dynamics but also significantly supports clinicians in making well-informed decisions regarding patient management, ultimately enhancing the quality of care delivered. Therefore, the integration of these advanced modules marks a significant advancement in cardiovascular imaging technology.

CryptoChart™ presents a secure and effective solution for transmitting patient medical images and records through a simple yet highly secure CryptoChart code. This unique code enables patients to access their images anytime and anywhere, facilitating easy sharing via text message or email. For assistance with CryptoChart, it is advisable to reach out to the facility where you initially obtained your information. By empowering your marketing team, you can significantly improve the experiences of both patients and physicians, giving your organization a unique competitive advantage. Additionally, IT demands can be lessened by employing a robust encryption strength of 25 characters, complemented by a random web access code for added security. The viewer is designed to work seamlessly across all mobile devices and desktops, ensuring convenience for all users. This innovative approach offers patients a quick and hassle-free way to manage and share their personal health information, ultimately enhancing their satisfaction and overall experience with the healthcare system. Furthermore, as patients become more engaged in their health management, organizations can build trust and foster long-term relationships.

Us2.ai is transforming the fight against heart disease by leveraging AI-powered ultrasound software, making heart health services available to a broader audience. This groundbreaking platform offers 45 automated echo parameters, including strain analysis, and facilitates real-time interpretation of both 2D and Doppler images. It integrates effortlessly with any ultrasound machine, generating comprehensive reports without any user input, all while ensuring high accuracy that can be easily benchmarked against expert assessments. The AI echo copilot from Us2.ai independently evaluates all heart chambers using 2D and Doppler imaging, providing detailed, real-time reports that adhere to global reference guidelines. Recently, the software received FDA approval for Us2.v2, which continues to include the 45 automated echo parameters like strain analysis, marking a significant leap forward in healthcare innovation. Us2.ai aspires to democratize echocardiography, making ultrasound technology accessible to everyone, irrespective of their geographic or socioeconomic status, which is essential for enhancing heart health universally. This dedication to innovation and inclusivity places Us2.ai at the leading edge of the medical technology industry, promising a future where advanced heart care is within reach of all individuals.

The D2P® software, which has received FDA clearance, works seamlessly with 3D Systems printers to enable healthcare professionals such as surgeons, radiologists, lab technicians, and device designers to create high-quality 3D models and physical prints for diagnostic purposes efficiently. By allowing users to import DICOM images directly into its standalone modular software, D2P simplifies the process of 3D model segmentation and preparation, all from a single workstation. As a medical device, this software not only aids in surgical planning but also facilitates the production of 3D-printed anatomical models for diagnostic applications. Its advanced image segmentation toolkit, coupled with immersive virtual reality (VR) visualization, minimizes the time and resources necessary for clinicians and point-of-care (POC) personnel to generate tailored anatomical models for their patients. In addition, the digital models produced through D2P are compatible with a variety of platforms like 3D printers, VR systems, surgical planning tools, and CAD software, which greatly enhances the adaptability and efficiency of medical practices. This cutting-edge methodology not only streamlines surgical preparations but also promotes teamwork among healthcare providers by equipping them with accurate and easily accessible anatomical representations, ultimately leading to improved patient outcomes. By bridging technology and medicine, D2P serves as a vital resource in advancing the capabilities of modern healthcare.

Implementing a thorough clinical decision support system throughout your organization is crucial for enhancing patient outcomes. By improving your PACS and EMR systems, you can optimize imaging workflows and elevate the quality of care provided to patients. Acknowledging the variety of images sourced from different modalities, it’s essential to ensure that your patients receive the best possible treatment. While a singular solution may work at times, leveraging an enterprise-level AI-driven imaging analysis can be fully realized with a modern technology framework and an easy-to-navigate interface designed for all healthcare providers. Whether it's for assessing radiologic images, planning procedures, or facilitating consultations at the care site, users can access a wide array of clinical resources via a sophisticated advanced UI or a simple web-based platform. TeraRecon excels at managing numerous imaging modalities and can support as many as 40 users simultaneously engaging in complex image processing from a single virtual server, unlike many competitors who often face limitations with multiple modalities or user support without necessitating extra servers. This adaptability and scalability not only underscore TeraRecon's leadership in imaging solutions but also highlight its commitment to enhancing clinical efficiency and patient care. By choosing TeraRecon, your organization can ensure that it stays at the forefront of technological advancements in medical imaging.

Merlin's CardioMotionTM echo analysis and reporting software, distributed by CDN in Australia, transforms the approach to quickly diagnosing cardiac issues. It is specifically tailored for use in various medical environments such as emergency departments, CCUs, ICUs, oncology suites, medical center practitioners, ultrasound labs, cardiology sections, and even in rural or isolated areas where point-of-care devices are essential. Additionally, it offers significant benefits for cardiac monitoring in clinical trials. What distinguishes Merlin CardioMotionTM is its unique capability to accurately process slow frame rate echo clips without requiring an ECG trace for detection, thus making it usable with lower-end ultrasound machines. Utilizing advanced image processing technology, the software is grounded in proprietary algorithms that enable the automatic detection of the ventricular wall and its borders. This cutting-edge methodology facilitates a rapid and accurate quantitative assessment of the heart's dynamic performance, leading to improved patient care and outcomes. Consequently, healthcare providers are empowered to make better-informed decisions regarding cardiac health management, ultimately promoting a higher standard of patient well-being.

Cutting-edge AI solutions that seamlessly integrate with your PACS and radiology workflows enable radiologists to optimize their processes and improve the quality of patient care. With the increasing demand for medical imaging, radiologists frequently find themselves inundated by vast amounts of data, which can result in more reporting errors, heavier workloads, and chaotic processes. AI technology alleviates this strain by automating repetitive tasks and standardizing measurements, allowing radiologists to generate high-quality, evidence-based reports more efficiently. This improvement not only supports referring doctors and physicians in making better-informed decisions but also cultivates a more streamlined workflow, ultimately enhancing patient care. Moreover, these systems are adept at accurately identifying, characterizing, and classifying critical elements while ensuring the highest standards of image quality and fast loading times. The integration of intelligent suggestions during report template searches, along with the option for pre-filled or customizable templates, significantly boosts standardized clinical communication and reporting efficiency. The adoption of such innovative tools empowers radiologists to devote more time to patient engagement and less to administrative tasks, fostering a more patient-centered approach in their practice. In addition, as the landscape of healthcare continues to evolve, embracing these technologies will be essential for radiology departments aiming to maintain their effectiveness and responsiveness to patient needs.

Materialise Mimics is a comprehensive software solution designed to convert medical imaging data into accurate 3D models, which can be utilized for various applications including the development of custom devices and in-depth anatomical research. The software features a wide range of tools that facilitate the planning, design, and 3D printing of models and surgical guides, catering to varying degrees of complexity and ensuring readiness for clinical use. At the heart of this platform lies Mimics Core, an advanced software dedicated to 3D medical image segmentation that seamlessly transitions from image acquisition to the production of 3D models. This capability supports virtual procedure planning and significantly enhances the platform's overall effectiveness. Furthermore, the Mimics Innovation Suite broadens the platform's functionalities by providing enhanced resources tailored for engineers and researchers. By making the interaction with 3D medical imaging data more straightforward, it serves as a vital resource for enhancing patient care through innovative technological solutions. In conclusion, this software not only connects cutting-edge imaging techniques with practical medical implementations but also fosters advancements in the healthcare industry by enabling better decision-making and improved surgical outcomes.

This versatile and customizable system is designed to accommodate a diverse array of healthcare environments, ranging from solo practitioner offices to large hospital systems and international clinical research entities. You can feel confident that your data is protected, removing the hassle of managing hardware and IT concerns. It meets and exceeds both HIPAA and PIPEDA standards for privacy protection and data security. Featuring an intuitive interface, the Studycast platform streamlines operations from the examination phase all the way to archiving. By utilizing optional integration features, the system effectively manages the entire process from ordering tests to delivering results. Studies can be uploaded effortlessly, as images, measurements, and patient data are automatically imported from the imaging equipment into the Studycast platform. Additionally, the zero-footprint viewer performs efficiently, granting access to diagnostic-quality images and video clips from any location with internet access, including mobile devices. This functionality allows healthcare providers to stay productive and deliver prompt patient care, regardless of their physical location. Ultimately, the system empowers medical professionals to enhance their workflow significantly while ensuring the highest standards of patient data security.

The EchoGo Heart Failure platform is transforming the identification of heart failure by utilizing artificial intelligence to improve the accuracy of detecting HFpEF through echocardiograms. In collaboration with the Mayo Clinic, this groundbreaking technology streamlines the detection process, achieving impressive precision from a single apical 4-chamber view, thereby overcoming longstanding challenges in diagnosing this condition. As the first AI-centric platform specifically focused on HFpEF detection in echocardiography, Ultromics establishes itself as a pioneer in the integration of AI for cardiac imaging solutions. Our cutting-edge technology not only facilitates earlier and more effective identification of heart failure but also aspires to enhance patients' overall quality of life. By offering a user-friendly and secure cloud-based Software-as-a-Service (SaaS) platform, Ultromics effortlessly integrates with current echocardiography systems, equipping labs with essential tools for accurate heart failure detection and efficient risk assessment. This innovation holds the potential to substantially reduce hospitalization rates associated with heart failure, providing significant advantages for both healthcare systems and patients. As we strive to push the boundaries of technology, our unwavering dedication is to advance cardiac care and improve patient outcomes. Furthermore, we aim to continually refine our services to meet the evolving needs of healthcare professionals and enhance patient experiences.

Vesalius3D is a cutting-edge software application that facilitates remarkable 3D visualization and examination of unique anatomical structures tailored to individual patients. This innovative tool allows users to examine fine details within a patient's anatomy that might be missed when using only conventional 2D imaging techniques. Featuring an intuitive interface, the software makes it easy to navigate through complex anatomical layers, ensuring a smooth user experience. Significantly, Vesalius3D is compatible with common medical imaging technologies such as CT, MRI, and Ultrasound, which means there is no requirement for specialized imaging to utilize its capabilities. It also includes presets that cater to the most commonly encountered types of tissue, enhancing the user experience further. Moreover, the software provides pre-set visualizations, enabling users to quickly access results without needing to make extensive manual adjustments, which is particularly beneficial for frequently examined tissues. In addition to visualization, Vesalius3D encompasses a variety of measurement tools that facilitate both 2D measurements—like distances, angles, and contour areas—and advanced 3D quantification to accurately evaluate shapes, contours, and spatial relationships. This extensive range of features greatly enhances the ability of healthcare professionals to efficiently gain deeper insights into patient anatomy. Consequently, Vesalius3D not only improves visualization but also streamlines the overall workflow for medical practitioners.

Brainlab's Elements Multiple Brain Metastases SRS is a state-of-the-art software designed to enhance both planning and execution of treatments for patients with multiple brain metastases. This advanced workflow empowers healthcare professionals to simultaneously address multiple metastases without exposing the entire brain to radiation, which considerably reduces the time required for treatment delivery. The process begins with pre-planning steps that leverage automation to perform tasks such as image fusion, distortion correction, outlining of objects, and segmentation, all of which improve the speed and accuracy of planning. Utilizing inverse-optimized dynamic conformal arc techniques centered on a single isocenter, the software achieves highly conformal dose distributions with precise gradients, ensuring that the targets receive accurate coverage while minimizing the impact on surrounding healthy tissue. This approach allows for the swift creation of consistent, high-quality radiosurgery plans in a matter of minutes, ultimately benefiting both clinicians and patients by shortening treatment times and improving overall outcomes. Additionally, the software's efficiency and effectiveness may contribute to greater patient satisfaction and a more streamlined workflow in clinical settings, thereby enhancing the overall healthcare experience. As a result, the integration of this technology not only optimizes treatment protocols but also reinforces the importance of innovative solutions in modern medicine.

The Butterfly iQ+ has been meticulously crafted to streamline the ultrasound process. Users can connect it to either an iOS or Android app, allowing them to quickly choose from 22 presets with a simple swipe of a finger, thus enabling instant scanning. Powered by our innovative Ultrasound-on-Chip™ technology, this device pushes the limits of traditional ultrasound methods. It features patented on-chip digital micro-beamforming, which enables frame rates that are 15% faster and pulse repetition frequencies that are 60% quicker than conventional systems. Additionally, its 1.75D array beamforming is designed to reduce elevation beamwidth by an impressive 85%. This device employs a state-of-the-art low-noise, low-power semiconductor process, along with optimized electronics and a power-efficient FPGA, ensuring top-notch performance. Users can simply connect it to their mobile devices and begin scanning immediately, all while benefiting from Butterfly Education resources. The vivid color representation provided by the iQ+ allows for precise illustrations of hemodynamic flow, giving healthcare professionals the clarity they need. As the only device in the world utilizing Ultrasound-on-Chip™ technology, it helps users efficiently detect A lines, B lines, and pleural irregularities, leading to faster and more accurate diagnostic results. This extraordinary tool not only improves scanning efficiency but also significantly enhances the standard of patient care. It stands out as a revolutionary advancement in medical imaging, making ultrasound more accessible and effective for practitioners everywhere.

InformAI focuses on developing artificial intelligence solutions aimed at improving medical diagnostics right at the point-of-care, while also increasing the productivity of radiologists. Our innovative AI-powered image classification tools and predictive analytics concerning patient outcomes are crafted in partnership with the Texas Medical Center, the largest medical center complex in the world. By collaborating with leading healthcare organizations, prestigious physician associations, and top-tier medical imaging companies, InformAI is actively transforming the landscape of healthcare delivery. Our team comprises specialists in healthcare, medicine, and artificial intelligence, united in their mission to create advancements that yield improved patient outcomes. Among our standout offerings is the InformAI Sinus Image Classifier, which employs a 3D convolutional neural network (CNN) and is trained on an extensive collection of 6 million radiology-validated 3D CT-scan images, underscoring our dedication to utilizing state-of-the-art technology in medicine. This strategy not only elevates diagnostic precision but also facilitates quicker and more effective patient care, ultimately enhancing the overall healthcare experience. Through these efforts, we aim to set new standards in medical diagnostics and patient treatment.

Remedico serves as a comprehensive Patient Relationship Management solution specifically tailored for dental practices, aiming to transform the landscape of dental care and clinic management. Key Features Smart Appointments™: An efficient scheduling platform that enhances clinic productivity. HyperRealistic™ 3D Dental Chart: Offers an intricate and interactive approach to patient charting. Treatment Case and Plan Management: Customizable plans that cater to the unique requirements of each patient. Patient Flow™: Enhances the overall patient experience by smoothing out their journey within the clinic. Set reminders for monitoring any patient or treatment plan effectively. Retention Booster™: Utilizes AI-driven communication strategies to bolster patient loyalty. Patient Quiz: Facilitates the easy collection of patients' personal and medical data. Dentaverse™: A groundbreaking VR application that allows for dynamic treatment visualizations. Through its innovative features, Remedico empowers dental clinics to adopt a cohesive approach that intertwines patient care, operational efficiency, and sustainable growth. This holistic integration ultimately leads to a more satisfying experience for both patients and practitioners alike.

EchoPixel's True3D software platform creates a holographic digital representation of a patient's heart, enabling surgical teams to carefully analyze and plan using a virtual model before any surgical incisions are made. This groundbreaking technology overcomes the limitations of traditional 2D imaging, offering a 4D interactive holographic environment that delivers real-time insights regarding the placement of catheters and implantable devices in intricate anatomical scenarios. True3D is applicable in numerous clinical contexts, including congenital heart defects like MAPCA, PA reconstruction, DORV, ASD, VSD, and CAVC, as well as in structural heart procedures such as LAAO, transseptal cross, TMVR, and TAVR. Esteemed medical institutions worldwide, such as Miyazaki University Hospital in Japan, have adopted this innovative platform, which has also received medical device registration in Japan. By employing True3D, healthcare practitioners can gain a more profound understanding of three-dimensional anatomical relationships, potentially resulting in reduced procedure times. The detailed visualization of a patient’s heart not only enhances preoperative planning but also contributes to improved surgical outcomes for patients. As the technology continues to evolve, it may play a vital role in the future of cardiac surgery.

Pulse is an innovative cloud-based solution tailored for echocardiography laboratories, focused on improving operational efficiency and patient care outcomes. This platform streamlines the processes of reporting, storage, and analysis of echocardiograms, ensuring that healthcare professionals can access vital patient data anytime and anywhere. Physicians enjoy the flexibility to review studies and complete reports from almost any location, making Pulse a crucial asset for modern echocardiography practices. Its interface is designed to be user-friendly and includes a powerful reporting system that is conveniently positioned alongside images and measurements, allowing users to carry out their tasks with ease. Additionally, Pulse incorporates AI-driven functionalities that enable automated measurements of GLS, LVEF, LVEDV, and LVESV, thereby eliminating the necessity for manual data entry. The platform also prioritizes data security while enhancing the benefits associated with cloud technology. Reports can be seamlessly transmitted to your electronic health record (EHR) through HL7, significantly optimizing clinical workflows. Users can effortlessly save new studies straight from the cart or access previously stored studies from an external PACS. Furthermore, the platform’s support for DICOM-TLS greatly eases the management of secure data access, removing the hassles often associated with VPN configurations. In summary, Pulse is transforming the echocardiography landscape by integrating advanced technology with clinical insight, ultimately setting a new standard for how laboratories operate efficiently. This innovative approach not only enhances the quality of care but also supports healthcare professionals in delivering timely and accurate diagnoses.

Our award-winning mobile visualization platform is designed to enhance collaboration among healthcare professionals, enabling them to diagnose patients while effortlessly accessing and sharing 2D and 3D medical images across multiple devices. By ensuring secure access to data from any location, the necessity for transferring or duplicating original files is completely eliminated. This platform is heavily favored by some of the largest and most advanced healthcare institutions around the world. Created by clinicians for their colleagues, the ResolutionMD enterprise viewer not only boosts patient care but also streamlines workflows with features that adhere to HIPAA regulations, all while offering strong mobile capabilities. With its FDA Class II certification and various international accreditations, you can trust that diagnoses made through both mobile and web applications are reliable, contributing to the delivery of high-quality care for patients everywhere. This forward-thinking solution not only enhances operational efficiency but also cultivates a collaborative atmosphere among healthcare providers, ultimately leading to better patient outcomes. Additionally, the platform's user-friendly interface ensures that healthcare professionals can focus on what truly matters: their patients.

Realize Medical's Elucis is an FDA-approved extended reality platform designed to enhance image segmentation, facilitate collaboration among dispersed teams, and enable procedural planning within a virtual reality environment. Capable of managing an unlimited array of 3D and 4D CT and MR images, Elucis ensures comprehensive project integration. It features state-of-the-art image processing tools that include both manual and automatic registration, along with the ability to visualize images in 2D, 3D, and 4D formats. The platform’s segmentation capabilities are crafted for both efficiency and ease of use, allowing for accurate measurement, cutting, and planning tasks to be performed directly in a virtual setting. Moreover, Elucis offers sophisticated 4D modeling functionalities that allow for detailed segmentation of cardiac structures in just minutes, irrespective of the phase. Users can import 3D structure files from external sources and conveniently export their projects with a single click. In addition, the platform fosters collaboration by enabling multiple users to connect effortlessly with local or remote colleagues throughout the entire process, making it an invaluable resource for healthcare professionals. This collaborative feature not only enhances communication but also ensures that every participant can make meaningful contributions to the project, ultimately improving outcomes in medical practice.

Zebra's Imaging Analytics Engine analyzes imaging scans from diverse modalities, performing automatic evaluations of various clinical findings, which promotes efficiency and seamless integration into the radiology workflow. Healthcare professionals depend on Zebra-Med to alert them about patients who face increased risks for cardiovascular, pulmonary, skeletal, and other health conditions. This advanced system plays a crucial role in reinforcing preventative care strategies, ensuring precise risk adjustments, and facilitating the achievement of quality standards such as MACRA. By leveraging Zebra-Med, medical practitioners can focus their attention on the most at-risk patients during critical situations, which ultimately leads to lower costs and improved patient care results. Additionally, this cutting-edge approach not only elevates the quality of care delivered but also enhances the overall allocation of resources throughout the healthcare landscape, benefiting both patients and providers in the long run.